Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir in COVID-19
NCT04497649Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Status: unknown.
02
Drugs
sofosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04497649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497649.